Free Trial
CVE:PTF

Pender Growth Fund (PTF) Stock Price, News & Analysis

Pender Growth Fund logo
C$14.00 +0.44 (+3.24%)
As of 07/7/2025

About Pender Growth Fund Stock (CVE:PTF)

Key Stats

Today's Range
C$13.58
C$14.01
50-Day Range
C$9.91
C$14.59
52-Week Range
C$9.29
C$14.99
Volume
1,325 shs
Average Volume
2,942 shs
Market Capitalization
C$101.51 million
P/E Ratio
2.26
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pender Growth Fund and its competitors with MarketBeat's FREE daily newsletter.

PTF Stock News Headlines

Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.
See More Headlines

PTF Stock Analysis - Frequently Asked Questions

Pender Growth Fund's stock was trading at C$11.19 on January 1st, 2025. Since then, PTF stock has increased by 25.1% and is now trading at C$14.00.

Shares of PTF stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pender Growth Fund investors own include Armata Pharmaceuticals (ARMP), BioCardia (BCDA), Bristol Myers Squibb (BMY), Range Cancer Therapeutics ETF (CNCR), Inovio Pharmaceuticals (INO), Insight Select Income Fund (INSI) and Protalix BioTherapeutics (PLX).

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Asset Management
Sub-Industry
N/A
Current Symbol
CVE:PTF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C$6.20
Trailing P/E Ratio
2.26
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$44.92 million
Net Margins
90.98%
Pretax Margin
N/A
Return on Equity
49.26%
Return on Assets
25.87%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
51.12

Sales & Book Value

Annual Sales
C$49.38 million
Price / Sales
2.06
Cash Flow
C$1.68 per share
Price / Cash Flow
8.35
Book Value
C$15.08 per share
Price / Book
0.93

Miscellaneous

Outstanding Shares
7,250,430
Free Float
N/A
Market Cap
C$101.51 million
Optionable
Not Optionable
Beta
0.56
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (CVE:PTF) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners